Hemodialysis & Peritoneal Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), Products (Hemodialysis Consumables & Supplies, Hemodialysis Equipment), Product Type, Disease Indication, Dialysis Site - Global Forecast 2024-2030

Hemodialysis & Peritoneal Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), Products (Hemodialysis Consumables & Supplies, Hemodialysis Equipment), Product Type, Disease Indication, Dialysis Site - Global Forecast 2024-2030

The Hemodialysis & Peritoneal Dialysis Market size was estimated at USD 84.37 billion in 2023 and expected to reach USD 89.75 billion in 2024, at a CAGR 6.56% to reach USD 131.71 billion by 2030.

Hemodialysis and peritoneal dialysis encompass the medical technologies, services, and associated products used in the treatment of kidney failure, also called as end-stage renal disease (ESRD). Hemodialysis (HD) involves filtering a patient's blood outside the body through a dialysis machine to remove waste products and excess fluids. On the other hand, peritoneal dialysis (PD) uses the patient's peritoneum (a membrane lining the abdomen) as a filter by instilling a dialysis solution into the abdominal cavity to absorb waste products that are drained away. Increasing rates of diabetes, hypertension, and other chronic diseases are primary drivers for the rise in kidney disease, subsequently boosting the demand for dialysis. However, the expense associated with dialysis treatment and related healthcare services is a significant deterrent, particularly in lower-income regions. Moreover, there is a rising trend in patient preference for home dialysis due to its convenience and potential cost-effectiveness. The development of wearable dialysis devices could revolutionize the market by making continuous dialysis a feasible and less intrusive option. In addition, the integration of digital health services in dialysis care could improve patient outcomes through better adherence and real-time monitoring.

Regional Insights

In the Americas, the United States and Canada are significant in the hemodialysis & peritoneal dialysis market due to the high prevalence of lifestyle diseases such as diabetes and better healthcare facilities. The region is substantial due to advanced healthcare infrastructure, high spending on healthcare, and extensive research and development activities. Medicare and other subsidies support patient access to necessary dialysis treatments. At the same time, in EMEA countries, an increase in elderly populations and favorable reimbursement policies are pivotal. EU boasts of a high adoption rate of dialysis treatments facilitated by government health policies, ensuring dialysis is accessible and often free at the point of service. Moreover, China, Japan, and India represent potential Asian Pacific markets due to their large populations and increasing prevalence of chronic kidney diseases (CKD). Rapid urbanization, an aging population, and a rise in diabetes and hypertension, which are major contributors to CKD, are driving the demand for dialysis treatments in these areas.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Hemodialysis & Peritoneal Dialysis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increasing prevalence of chronic and acute kidney disorders worldwide
Growing consumer preference for home dialysis treatments
Shortage of organ donors and risks associated with kidney transplants

Market Restraints

Concerns regarding product recall and reimbursement policies

Market Opportunities

Technological advancements in hemodialysis & peritoneal dialysis products
Increasing investments to develop dialysis centers in developing economies

Market Challenges

Risks and complications of dialysis

Market Segmentation Analysis

Type: Utilization of hemodialysis in CKD to remove unwanted toxins and manage fluid balance
Disease Indication: Increasing adoption of hemodialysis & peritoneal dialysis in the treatment of chronic renal diseases

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hemodialysis & Peritoneal Dialysis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hemodialysis & Peritoneal Dialysis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Fresenius Medical Care Secures FDA Clearance for Advanced Hemodialysis System

Fresenius Medical Care announced its receipt of FDA 510(k) clearance for its 5008X Hemodialysis System, marking a significant advancement in dialysis treatment in the United States. This approval paves the way for Fresenius to deliver a new standard of care to American patients suffering from kidney diseases, promising improvements in treatment efficacy and patient well-being with this innovative technology.

FDA Grants Approval for DefenCath as Antimicrobial Solution for Hemodialysis Patients

The FDA has endorsed DefenCath, developed by CorMedix Inc., a catheter lock solution combining taurolidine and heparin designed for adult patients undergoing chronic hemodialysis via a central venous catheter. This new treatment aims to provide an antimicrobial protective measure for these patients, enhancing the safety and effectiveness of their dialysis procedures.

Launch of the Inpatient Hemodialysis Program at Rancho Los Amigos National Rehabilitation Center

Rancho Los Amigos National Rehabilitation Center introduces its Inpatient Hemodialysis Program, a significant advancement in the hospital's rehabilitation services. This new initiative highlights Rancho's dedication to medical innovation and underscores its commitment to enhancing patient care. The program is designed to provide comprehensive and continuous care to patients undergoing rehabilitation, ensuring they receive optimal treatment within the facility. This development further establishes Rancho Los Amigos as a leader in implementing forward-thinking healthcare solutions.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hemodialysis & Peritoneal Dialysis Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Hemodialysis & Peritoneal Dialysis Market, highlighting leading vendors and their innovative profiles. These include Allmed Medical Products Co., Ltd., AngioDynamics, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, DaVita Inc., Dialife SA, Evoqua Water Technologies LLC, Fresenius Medical Care AG, Hemoclean Co. Ltd., JMS Co., Ltd., Medtronic PLC, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical Inc., Rockwell Medical Inc., SB-KAWASUMI LABORATORIES, INC., STERIS Group, Toray Medical Co., Ltd., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Hemodialysis & Peritoneal Dialysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Hemodialysis
Peritoneal Dialysis
Products
Hemodialysis Consumables & Supplies
Bloodlines
Catheters
Dialysate
Hemodialysis Equipment
Dialysis Machines
Dialyzers
Water Treatment Systems
Product Type
Central Water Disinfectant Systems
Portable Dialysis Water Disinfectant Systems
Disease Indication
Acute Kidney Infections
Chronic Renal Disease
Multi-Organ Failure
Septic Shock
Dialysis Site
Clinics & Dialysis Centers
Home Care Settings
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year